Internal Medicine · Oakland, CA
NPI
1457330839
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
275 W Macarthur Blvd
Oakland, CA, 94611
Phone (510) 752-1000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
396 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jeanette C Yu prescribed most often to Medicare patients was Imatinib Mesylate, with 39 prescriptions and refills. In total Jeanette C Yu wrote 396 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Imatinib Mesylate Generic | 39 | 47 | Under 11 | $2,196 |
| Ondansetron Hcl Generic | 32 | 32 | 16 | $280 |
| Prochlorperazine Maleate Generic | 31 | 31 | 18 | $441 |
| Tagrisso Osimertinib Mesylate | 20 | 20 | Under 11 | $343K |
| Tamoxifen Citrate Generic | 20 | 67 | 12 | $532 |
| Anastrozole Generic | 18 | 54 | 13 | $504 |
| Prednisone Generic | 13 | 13 | Under 11 | $81.8 |
| Stivarga Regorafenib | 12 | 12 | Under 11 | $211K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 12 | 12 | 11 | $1,147 |
| Dexamethasone Generic | 12 | 16 | Under 11 | $206 |
| Sutent Sunitinib Malate | 11 | 11 | Under 11 | $232K |
| Abiraterone Acetate Generic | 11 | 11 | Under 11 | $1,670 |
| Alecensa Alectinib Hcl | 11 | 11 | Under 11 | $221K |
| Famotidine Generic | 11 | 27 | Under 11 | $235 |
| Letrozole Generic | 11 | 13 | Under 11 | $243 |
Brand drugs: 102 claims; generic drugs: 294 claims; opioid claims: 26.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jeanette C Yu were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.